FNRS / Televie Grants: Congratulations to all applicants!
-
Research Director
Bénédicte Jordan, REMA
Imaging metabolic plasticity in cancer in the transition towards personalized therapy.
- Senior Research Associate
Anne des Rieux, ADDB
New drug and stem cell delivery systems for innovative central nervous system therapies
- Research credit 3 years
Chiara Bastiancich, ADDB, Véronique Préat
Development of a nanomedicine-loaded local treatment for glioblastoma able to target the tumor resection microenvironmentand avoid the onset of recurrences (GlioRET)
- Research Fellow
Antoine Christiaens, Research Fellow Renewal, CLIP, Séverine Henrard
Elderly-onset type 2 diabetes: description, pathophysiology and therapeutical implication
Hafsa Ameraoui, Research Fellow, BPBL, Giulio Muccioli
Research Fellow Contribution to the study of oxysterols in inflammatory bowel diseases: from their quantification in patients to the study of theirproperties in vitro and in vivo
Alexandra Degraeve, Research Fellow, PMGK, Laure Elens
Tacrolimus pharmacokinetic pathway and microbiota: study of the complex bidirectional partnership for explaining metabolicvariability and modulations
Juliette Lagreula, Research Fellow, CLIP, Olivia Dalleur
Optimizing pharmacotherapy of antipsychotics in clinical daily practice : Moving towards individualized care
- Starting Grant
Amandine Everard, MNut
Identification of gut microbes and metabolites involved in the gut-to-brain axis controlling hedonic and reward system during food intake
- Continuation Grant Renewal
Patrice Cani, MNut
Targeting NAPE-PLD, novel bioactive lipids and specific gut microbes to improve cardiometabolic disorders associated with obesity
- Télévie Classique
Raphaël Frédérick (CMFA)
Macrocyclic peptides as LDHB disruptors for cancer therapy
Bénédicte Jordan (REMA), Patrice Cani (MNUT)
Impact of bioactive lipids on tumor cell metabolism and breast cancer progression: novel insight from obesity and the gut microbiota
Bernard Gallez (REMA), Véronique Préat (ADDB)
Strategies for a transient opening of the blood brain barrier to increase the delivery of nanomedicines to glioblastoma
Bénédicte Jordan (REMA), Jean-François Baurain
Disrupting lactate shuttling and glutamine pathway in melanoma : relevance of metabolic targeting in combination with BRAF or immune checkpoint inhibitors
We also would like to congratulate Raphaël Frédérick (CMFA) and Anne des Rieux (ADDB) that have been promoted as UCLouvain “Professors”.